iSRS 2022
Published by: Society of Radiopharmaceutical Sciences
Description
iSRS 2021 (Nantes, France) aims to address original research in all aspects of radiopharmaceutical science; synthesis, in vitro and ex vivo studies, in vivo biodistribution or imaging, radiopharmacology, radiopharmacy, and translational clinical studies of new targeted radiotracers.
Screenshots
iSRS 2022 FAQ
-
Is iSRS 2022 free?
Yes, iSRS 2022 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is iSRS 2022 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does iSRS 2022 cost?
iSRS 2022 is free.
-
What is iSRS 2022 revenue?
To get estimated revenue of iSRS 2022 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Czechia yet.
Ratings History
iSRS 2022 Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
iSRS 2022 Installs
Last 30 days
iSRS 2022 Revenue
Last 30 daysiSRS 2022 Revenue and Downloads
Gain valuable insights into iSRS 2022 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Education
- Publisher
- Society of Radiopharmaceutical Sciences
- Languages
- English
- Recent release
- 1.0 (2 years ago )
- Released on
- May 14, 2022 (2 years ago )
- Also available in
- Argentina, Australia, Belgium, Canada, Czechia, Japan, Kazakhstan, Mexico, New Zealand, United States, Vietnam
- Last Updated
- 1 month ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.